Today: The 2,545 Shares of athenahealth Inc. (ATHN) Stock are sold by Bradford Kyle Armbrester

The 2,545 Shares of athenahealth Inc. (ATHN) Stock are sold by Bradford Kyle Armbrester

athenahealth Inc. (NASDAQ:ATHN) SVP Bradford Kyle Armbrester sold 2,545 shares of athenahealth stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $130.00, for a total value of $330,850.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

athenahealth Inc. (NASDAQ:ATHN) opened at 126.34 on Friday. athenahealth Inc. has a 52 week low of $114.59 and a 52 week high of $170.42. The company has a market capitalization of $4.97 billion, a price-to-earnings ratio of 464.49 and a beta of 1.28. The firm has a 50-day moving average price of $123.69 and a 200-day moving average price of $129.72.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 21st. The company reported $0.34 EPS for the quarter, missing the consensus estimate of $0.42 by $0.08. athenahealth had a net margin of 1.06% and a return on equity of 5.16%. The business had revenue of $261.90 million for the quarter, compared to analysts’ expectations of $274.07 million. Analysts anticipate that athenahealth Inc. will post $1.77 EPS for the current fiscal year.

ATHN has been the topic of several analyst reports. Leerink Swann reaffirmed a “hold” rating on shares of athenahealth in a research report on Thursday, June 16th. Canaccord Genuity reissued a “hold” rating and issued a $142.00 price objective on shares of athenahealth in a research report on Wednesday, June 29th. Zacks Investment Research cut athenahealth from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 12th. Deutsche Bank AG cut athenahealth from a “buy” rating to a “hold” rating and cut their price objective for the stock from $165.00 to $147.00 in a research report on Friday, July 22nd. Finally, FBR & Co cut their price objective on athenahealth from $145.00 to $140.00 and set a “market perform” rating on the stock in a research report on Friday, July 22nd. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and nine have given a buy rating to the company. athenahealth has a consensus rating of “Hold” and an average target price of $149.70.

Institutional investors have recently added to or reduced their stakes in the company. Glenmede Trust Co. NA increased its position in athenahealth by 66.3% in the first quarter. Glenmede Trust Co. NA now owns 6,253 shares of the company’s stock worth $867,000 after buying an additional 2,492 shares during the period. Aperio Group LLC increased its position in athenahealth by 11.6% in the first quarter. Aperio Group LLC now owns 3,429 shares of the company’s stock worth $476,000 after buying an additional 357 shares during the period. Pacad Investment Ltd. purchased a new position in athenahealth during the first quarter worth about $222,000. Franklin Resources Inc. increased its position in athenahealth by 10.8% in the first quarter. Franklin Resources Inc. now owns 544,811 shares of the company’s stock worth $75,609,000 after buying an additional 53,300 shares during the period. Finally, BlackRock Inc. increased its position in athenahealth by 273.8% in the first quarter. BlackRock Inc. now owns 4,508 shares of the company’s stock worth $625,000 after buying an additional 3,302 shares during the period.

About athenahealth

Related posts

Leave a Comment